Related Experiment Video
Updated: Jun 27, 2026
09:01
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Deferoxamine therapy for intracerebral hemorrhage.
1Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109-2200, USA.
Acta Neurochirurgica. Supplement
|December 11, 2008
Summary
Intracerebral hemorrhage (ICH) causes brain injury due to iron overload. Iron chelation therapy using deferoxamine effectively reduced brain edema, neuronal death, and neurological deficits in rats, suggesting a potential new treatment for ICH.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Intracerebral hemorrhage (ICH) is a severe stroke subtype with high mortality.
- Clot lysis and iron accumulation are implicated in ICH-induced brain damage.
- Iron overload in the brain post-ICH contributes to edema and neuronal death.
Purpose of the Study:
- To investigate the therapeutic potential of deferoxamine, an iron chelator, in a rat model of ICH.
- To determine if deferoxamine can mitigate ICH-induced brain injury.
Main Methods:
- Intracerebral hemorrhage was induced in rats.
- Deferoxamine, an FDA-approved iron chelator, was administered systemically.
- Effects on brain edema, neuronal death, brain atrophy, and neurological deficits were assessed.
Main Results:
- Iron overload was confirmed in the rat brain after ICH.
- Deferoxamine treatment significantly reduced ICH-induced brain edema.
- Deferoxamine administration decreased neuronal death, brain atrophy, and neurological deficits.
Conclusions:
- Iron chelation with deferoxamine demonstrates neuroprotective effects in an ICH model.
- Deferoxamine shows promise as a novel therapeutic strategy for intracerebral hemorrhage.
- Targeting iron overload could be a viable approach for managing ICH.
Related Concept Videos
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...